Viewing Study NCT01460602

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-04-29 @ 10:28 PM
Study NCT ID: NCT01460602
Status: WITHDRAWN
Last Update Posted: 2020-09-01
First Post: 2010-06-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Velcade, Nipent, Rituxan (VNR) in Subjects With Relapsed Follicular, Marginal Zone, and Mantle Cell Lymphoma
Sponsor: Louisiana State University Health Sciences Center Shreveport
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Follicular Lymphoma View
None Marginal Zone Lymphoma View
None Mantle Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None Follicular View
None Marginal Zone View
None Mantle Cell View
None Velcade View
None bortezomib View
None Nipent View
None pentastatin View
None Rituxan View
None rituximab View
None Turturro View
None Shreveport View